Bio Island DHA
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
27-11-2017
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
docosahexaenoic acid (DHA)-rich oil derived from microalgae Schizochytrium sp., Quantity: 250 mg (Equivalent: docosahexaenoic acid, Qty 100 mg)
Available from:
JBX Pty Ltd
INN (International Name):
docosahexaenoic acid (DHA)-rich oil derived from microalgae Schizochytrium sp.
Pharmaceutical form:
Capsule, soft
Composition:
Excipient Ingredients: Linseed Oil; Gelatin; purified water; glycerol; d-alpha-tocopherol
Administration route:
Oral
Class:
Medicine Listed
Therapeutic indications:
Maintain/support healthy growth and development
Product summary:
Visual Identification: ;
Authorization status:
Licence status A
Authorization date:
2012-10-22
